BioClever 2005 S.L.
BioClever 2005 S.L.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AEF0217 in Participants With Down Syndrome | Abnormalities, Multiple, Cognition Disorders, Cognitive Dysfunction, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, cognitive disorder, hereditary disease, intellectual disability, nervous system disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-04-08 | NCT07334912 | |
| Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-03-11 | NCT05679895 | |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Recruiting | Phase 3 | 2025-05-13 | NCT04435990 |